Castle Biosciences (CSTL) Change in Inventory (2018 - 2026)

Castle Biosciences (CSTL) has 9 years of Change in Inventory data on file, last reported at $207000.0 in Q1 2026.

• Quarterly Change in Inventory rose 116.1% year-over-year to $207000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 556.66% YoY) and the FY2025 annual result came in at $2.1 million, up 1009.84% from the prior year.
• Change in Inventory declined to $207000.0 in Q1 2026 per CSTL's latest filing, from $1.6 million in the prior quarter.
• The five-year high for Change in Inventory was $2.2 million in Q4 2023, with the low at -$1.4 million in Q3 2024.
• Average Change in Inventory over 5 years is $481411.8, with a median of $368000.0 recorded in 2024.
• Year-over-year, Change in Inventory surged 1120.79% in 2023 and slumped 333.0% in 2025.
• Castle Biosciences' Change in Inventory stood at $178000.0 in 2022, then surged by 1120.79% to $2.2 million in 2023, then fell by 28.07% to $1.6 million in 2024, then advanced by 2.62% to $1.6 million in 2025, then slumped by 87.09% to $207000.0 in 2026.
• Business Quant data shows CSTL's Change in Inventory at $207000.0 in Q1 2026, $1.6 million in Q4 2025, and $307000.0 in Q3 2025.